.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for inclusion of people with MASLD as well as size of liver outcomes in cardio-- renal-- metabolic tests, when records propose mechanistically possible benefits and also medical safety-- and also lays out considerations for test style as well as governing approval.